An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
DexCom, Inc. (NASDAQ:DXCM) will announce its first quarter 2023 financial results on April 27, 2023, after market close. Management will host a conference call at 4:30 p.m. ET to discuss performance, which will also be available via webcast on the investors.dexcom.com site. Participants can listen by dialing (888) 414-4585 for US/Canada or (646) 960-0331 for international calls, using the confirmation ID "9430114". As a leader in diabetes care, DexCom focuses on empowering users through continuous glucose monitoring (CGM) systems, enhancing diabetes management globally.
Positive
Upcoming financial results announcement for Q1 2023 may provide insights into growth metrics.
Planned conference call allows investors to engage directly with management.
Negative
None.
SAN DIEGO--(BUSINESS WIRE)--
DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its first quarter 2023 financial results after market close on Thursday, April 27, 2023. Management will hold a conference call to review the company's first quarter 2023 performance starting at 4:30 p.m. (Eastern Time) on the same day. The conference call will be concurrently webcast. The link to the webcast will be available on the Dexcom investor relations website at investors.dexcom.com and will be archived there for future reference.
To listen to the conference call, please dial (888) 414-4585 (US/Canada) or (646) 960-0331 (International) and use the confirmation ID "9430114" approximately five minutes prior to the start time.
About DexCom, Inc.
DexCom, Inc. empowers people to take control of health through innovative continuous glucose monitoring (CGM) systems. Headquartered in San Diego, California, and with operations across Europe and select parts of Asia/Oceania, Dexcom has emerged as a leader of diabetes care technology. By listening to the needs of users, caregivers, and providers, Dexcom simplifies and improves diabetes management around the world. For more information about Dexcom CGM, visit www.dexcom.com.
DexCom, Inc.:
Sean Christensen Vice President – Finance and Investor Relations
investor-relations@dexcom.com
(858) 200-0200
Source: DexCom, Inc.
FAQ
When will DexCom release its first quarter 2023 financial results?
DexCom will release its first quarter 2023 financial results on April 27, 2023, after market close.
What time is the conference call for DexCom's Q1 2023 financial results?
The conference call will be held at 4:30 p.m. ET on April 27, 2023.
How can I listen to the DexCom conference call?
You can listen to the DexCom conference call by dialing (888) 414-4585 for US/Canada, or (646) 960-0331 for international access, using confirmation ID '9430114'.
Where can I find the webcast of the DexCom conference call?
The webcast of the DexCom conference call will be available on the investors.dexcom.com website.
